AVXT Projected Dividend Yield
AVAX Technologies, Inc. ( OTCBB : AVXT )AVAX Technologies is a development stage biotechnology company specializing in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. Co.'s vaccine consists of autologous (the patient's own) cancer cells that have been treated with a chemical ("haptenized") to make them more visible to the patient's immune system. Co.'s previous clinical trials for the AC Vaccine have concentrated on melanoma, ovarian carcinoma and non-small cell lung cancer. Co. also offers biological manufacturing services to other biotechnology and pharmaceutical companies. 21 YEAR PERFORMANCE RESULTS |
AVXT Dividend History Detail AVXT Dividend News AVXT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |